Chargement en cours...
A vaccine manufacturer’s approach to address medical needs related to seasonal and pandemic influenza viruses
Abstract Vaccination is considered to be one of the most effective tools to decrease morbidity as well as mortality caused by influenza viruses. For the prevention of seasonal influenza, Fluarix ™ and FluLaval™ have been marketed since 1987 and 1992, respectively. Both vaccines have consistently bee...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Blackwell Publishing Ltd
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2710798/ https://ncbi.nlm.nih.gov/pubmed/19453402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1750-2659.2008.00054.x |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|